Market research

Enteral Pumps & Sets

Explore licenses

360iResearch introduction

Enteral Pumps and Sets: Executive Summary

Enteral pumps and sets support controlled delivery of liquid nutrition through feeding tubes when oral intake is inadequate or unsafe. Demand is shaped by hospital care, home enteral nutrition, aging populations, chronic disease, neonatal and pediatric care, and the need to reduce complications associated with manual feeding. Clinical priorities increasingly include accurate flow control, usability, infection prevention, interoperability, and continuity of care across hospitals and home settings.

Inside the research

Coverage at a glance

Selected branches from the published table of contents. Follow a chapter to explore its complete hierarchy.

  1. Chapter 7 Product Type

    • Pump
    • Sets
    View chapter
  2. Chapter 8 Mode Of Delivery

    • Continuous Feeding
    • Intermittent Feeding
    View chapter
  3. Chapter 9 Technology

    • Wired Connectivity
    • Wireless Connectivity
    View chapter

Care Delivery Is Shifting Toward Connected, Home-Based Nutrition

The landscape is being reshaped by shorter hospital stays, growth in home-based care, and greater emphasis on coordinated transitions from inpatient to outpatient settings. These changes increase the importance of portable pumps, easy-to-use administration sets, reliable battery performance, and standardized training for caregivers. Infection-control expectations are also encouraging closed-system designs, simplified handling, and clearer instructions for preparation, storage, and disposal. Reimbursement rules, procurement standards, tube-feeding protocols, and clinician familiarity remain important adoption factors.

Artificial Intelligence Is Improving Monitoring and Workflow Support

Artificial intelligence can contribute to enteral nutrition through anomaly detection, decision support, predictive maintenance, and workflow automation. Connected pumps may use analytics to identify interruptions, occlusions, flow irregularities, or adherence patterns, while clinical systems can help relate feeding records to patient tolerance and prescribed regimens. The strongest near-term applications are likely to support-not replace-clinical judgment. Successful deployment requires validated algorithms, high-quality device data, cybersecurity controls, interoperability with health-information systems, and transparent processes for reviewing alerts and avoiding alarm fatigue.

Regional Insights: Regulation, Infrastructure, and Care Models Differ

North America combines advanced hospital infrastructure with established home-care pathways, making usability, connectivity, reimbursement, and supply continuity important priorities. Europe emphasizes patient safety, device regulation, sustainability, and cross-border standards, while the European care environment varies by national reimbursement and procurement systems. Asia-Pacific presents a broad mix of mature healthcare systems, expanding hospital capacity, neonatal and elderly-care needs, and uneven access between urban and rural areas. Latin America is influenced by public-sector purchasing, import requirements, and differences in home-care availability. The Middle East is investing in specialized healthcare and medical technology while often relying on centralized procurement. Africa faces substantial variation in infrastructure, workforce capacity, electricity reliability, and access to nutrition support, increasing the value of robust, low-maintenance equipment and training.

Group Insights: Economic and Institutional Coordination Shapes Adoption

ASEAN markets reflect varied regulatory systems, healthcare financing models, and distribution capabilities, creating a need for adaptable products and local training. BRICS countries span large and diverse patient populations, with opportunities linked to domestic manufacturing, public procurement, and expansion of specialized care, alongside differences in standards and infrastructure. The European Union benefits from coordinated regulatory principles but retains national variation in purchasing and reimbursement. G7 healthcare systems generally place strong emphasis on evidence, patient safety, home care, and digital integration. GCC countries are strengthening specialized and private healthcare capacity, with centralized purchasing and workforce development influencing implementation. NATO members represent diverse healthcare markets, yet resilience, emergency preparedness, and dependable medical supply chains are common strategic concerns.

Country Insights: Diverse Health Systems Require Localized Execution

Australia and Canada must address dispersed populations, home-care logistics, and equitable access across remote areas. Brazil, Mexico, India, and Russia combine large geographic footprints with marked differences in public and private provision, making distribution, training, and procurement localization central considerations. China is expanding advanced healthcare capacity while emphasizing domestic supply resilience and regulatory compliance. Japan, South Korea, Germany, France, Italy, Spain, and the United Kingdom have mature clinical systems where evidence, workflow integration, safety, and aging-related nutrition needs influence adoption. The United States has substantial hospital and home-care demand, with purchasing shaped by clinical protocols, reimbursement, compliance, and interoperability. Across all countries, pediatric requirements, caregiver capability, electricity reliability, and post-sale service affect real-world performance.

Action Priorities for Leaders in Enteral Nutrition Delivery

Industry leaders should design portfolios around distinct hospital, ambulatory, and home-care workflows rather than treating all users as interchangeable. Products should prioritize intuitive operation, accurate delivery, secure connections, compatibility with prescribed feeding regimens, and clear cleaning and disposal instructions. Organizations should build evidence around patient safety, reduction of interruptions, caregiver usability, and total workflow burden. They should also strengthen supplier resilience through qualified alternatives, regional service capacity, and contingency planning. Digital features should be introduced with cybersecurity, interoperability, human oversight, and measurable clinical objectives. Finally, leaders should engage clinicians, dietitians, nurses, caregivers, regulators, and procurement teams early so that product design and implementation reflect local requirements.

Research Methodology: Evidence-Based Market Assessment

This executive summary uses a structured review of publicly available clinical, regulatory, healthcare-system, and technology evidence relevant to enteral pumps and administration sets. The assessment considers care settings, patient needs, device functionality, infection prevention, digital integration, procurement conditions, infrastructure, and regional differences. Geographic and group comparisons are qualitative and focus on verified structural factors rather than market estimates or forecasts. Findings should be interpreted alongside local clinical guidelines, regulatory requirements, reimbursement policies, and institutional procurement criteria. Because product performance and adoption can vary by setting, implementation conclusions should be validated through local stakeholder consultation and real-world evaluation.

Conclusion: Reliable, Connected, and Accessible Feeding Support

Enteral pumps and sets are becoming more important as healthcare systems manage complex nutrition needs across hospitals, facilities, and homes. The central opportunity is not simply greater device availability, but dependable delivery embedded within safe, coordinated care pathways. Leaders that combine ergonomic design, infection-control support, resilient supply, evidence-based implementation, and responsible digital capabilities will be better positioned to serve varied patient populations. Progress will depend on adapting solutions to regional infrastructure, regulatory expectations, workforce capacity, and caregiver realities while preserving patient safety and clinical accountability.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.Enteral Pumps & Sets Market, by Product Type
    1. 7.1Introduction
    2. 7.2Pump
      1. 7.2.1Ambulatory Pump
        1. 7.2.1.1Traditional Ambulatory Pump
        2. 7.2.1.2Wearable Pump
      2. 7.2.2Stationary Pump
        1. 7.2.2.1Homecare Pumps
        2. 7.2.2.2Hospital Pumps
    3. 7.3Sets
      1. 7.3.1Enfit Sets
      2. 7.3.2Standard Sets
  8. 8.Enteral Pumps & Sets Market, by Mode Of Delivery
    1. 8.1Introduction
    2. 8.2Continuous Feeding
    3. 8.3Intermittent Feeding
  9. 9.Enteral Pumps & Sets Market, by Technology
    1. 9.1Introduction
    2. 9.2Wired Connectivity
    3. 9.3Wireless Connectivity
  10. 10.Enteral Pumps & Sets Market, by Application
    1. 10.1Introduction
    2. 10.2Home Care
    3. 10.3Hospital
    4. 10.4Long-Term Care
  11. 11.Enteral Pumps & Sets Market, by End User
    1. 11.1Introduction
    2. 11.2Ambulatory Care Centers
    3. 11.3Homecare Settings
    4. 11.4Hospitals
  12. 12.Enteral Pumps & Sets Market, by Distribution Channel
    1. 12.1Introduction
    2. 12.2Hospital Pharmacies
    3. 12.3Online Retail
    4. 12.4Retail Pharmacies
  13. 13.Enteral Pumps & Sets Market, by Region
    1. 13.1Introduction
    2. 13.2Asia-Pacific
    3. 13.3North America
    4. 13.4Latin America
    5. 13.5Europe
    6. 13.6Middle East
    7. 13.7Africa
  14. 14.Enteral Pumps & Sets Market, by Group
    1. 14.1Introduction
    2. 14.2ASEAN
    3. 14.3GCC
    4. 14.4European Union
    5. 14.5BRICS
    6. 14.6G7
    7. 14.7NATO
  15. 15.Enteral Pumps & Sets Market, by Country
    1. 15.1Introduction
    2. 15.2United States
    3. 15.3Canada
    4. 15.4Mexico
    5. 15.5Brazil
    6. 15.6United Kingdom
    7. 15.7Germany
    8. 15.8France
    9. 15.9Russia
    10. 15.10Italy
    11. 15.11Spain
    12. 15.12China
    13. 15.13India
    14. 15.14Japan
    15. 15.15Australia
    16. 15.16South Korea
  16. 16.Competitive Landscape
    1. 16.1Market Share Analysis, 2025
    2. 16.2Market Concentration Analysis, 2025
      1. 16.2.1Concentration Ratio (CR)
      2. 16.2.2Herfindahl Hirschman Index (HHI)
    3. 16.3Recent Developments & Impact Analysis, 2025
    4. 16.4Product Portfolio Analysis, 2025
    5. 16.5Benchmarking Analysis, 2025
  17. 17.Company Profiles
    1. 17.1ALCOR Group, Inc.
    2. 17.2Amsino International, Inc.
    3. 17.3Applied Medical Technology, Inc.
    4. 17.4Avanos Medical, Inc.
    5. 17.5B. Braun Melsungen AG
    6. 17.6Baxter International Inc.
    7. 17.7Becton Dickinson and Company
    8. 17.8Cardinal Health, Inc.
    9. 17.9ConMed Corporation
    10. 17.10Cook Medical LLC
    11. 17.11Fresenius Kabi AG
    12. 17.12ICU Medical, Inc.
    13. 17.13Jiangsu Yakai Medical Technology Co., Ltd.
    14. 17.14Kimberly-Clark Corporation
    15. 17.15Koninklijke Philips N.V.
    16. 17.16Medline Industries, L.P.
    17. 17.17Medtronic plc
    18. 17.18Moog Inc.
    19. 17.19Suzhou Zede Medical Equipment Co., Ltd.
    20. 17.20Terumo Corporation
    21. 17.21Vygon SA
  18. 18.Key Experts

Loading the sample request form…